Maternal SARS-CoV-2 Infection at Delivery Increases IL-6 Concentration in Umbilical Cord Blood
Journal of Clinical Medicine · 31.08.2023 · 12 (17) · 5672
DOI: 10.3390/jcm12175672 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 31.08.2023. Verfasst von Katarzyna Kosińska-Kaczyńska und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics, Perinatology and Neonatology, Center of Postgraduate Medical Education, 01-809 Warsaw, Poland. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Center of Postgraduate Medical Education, Centre of Postgraduate Medical Education.
Abstract (Originalsprache)
Background
SARS-CoV-2 infection in pregnant women may induce inflammation within the amniotic cavity and/or an increase in proinflammatory cytokines in fetal circulation. The aim was to investigate levels of IL-6 in maternal blood, umbilical cord blood, and amniotic fluid in pregnant women infected with SARS-CoV-2 at delivery.
Methods
A single-center prospective observational case–control study of pregnant women diagnosed with SARS-CoV-2 infection at delivery was conducted. A total of 48 infected and 42 healthy women had IL-6 concentrations measured in their blood, amniotic fluid, and umbilical cord blood.
Results
The concentrations of IL-6 in maternal blood and amniotic fluid were similar in the study and control groups, while umbilical cord blood concentrations were significantly higher in SARS-CoV-2-positive women. The umbilical cord blood IL-6 concentration was related to composite neonatal morbidity.
Conclusions
Maternal SARS-CoV-2 infection in pregnant women at delivery increases umbilical cord blood IL-6 concentration. The correlation between maternal and umbilical blood concentrations indicates a possibility of passage of IL-6 through the placenta. Perinatal alterations resulting from maternal SARS-CoV-2 infection at delivery carry a risk of impacting the health of infants even in asymptomatic course of infection.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics, Perinatology and Neonatology, Center of Postgraduate Medical Education, 01-809 Warsaw, Poland.
- Central Analytical Laboratory, Warsaw Infectious Diseases Hospital, 01-201 Warsaw, Poland.
- Department of Medical Microbiology, Medical University of Warsaw, 02-091 Warsaw, Poland.
ORCID-Profile: Katarzyna Kosińska-Kaczyńska, Beata Rebizant, Maciej Przybylski, Robert Brawura-Biskupski-Samaha
Förderung
- Center of Postgraduate Medical Education
- Centre of Postgraduate Medical Education
Zitieren
APA
Kosińska-Kaczyńska, K., Rebizant, B., Czeszko-Paprocka, H., Bojdo, A., Przybylski, M., Chaberek, K., Lewandowska, A., Szymusik, I., & Brawura-Biskupski-Samaha, R. (2023). Maternal SARS-CoV-2 Infection at Delivery Increases IL-6 Concentration in Umbilical Cord Blood. Journal of Clinical Medicine, 12(17), 5672. https://doi.org/10.3390/jcm12175672
Vancouver
Kosińska-Kaczyńska K, Rebizant B, Czeszko-Paprocka H, Bojdo A, Przybylski M, Chaberek K, et al. Maternal SARS-CoV-2 Infection at Delivery Increases IL-6 Concentration in Umbilical Cord Blood. Journal of Clinical Medicine. 2023;12(17):5672. doi:10.3390/jcm12175672
BibTeX
@article{KosiskaKaczyska2023,
author = {Kosińska-Kaczyńska, Katarzyna and Rebizant, Beata and Czeszko-Paprocka, Hanna and Bojdo, Agata and Przybylski, Maciej and Chaberek, Katarzyna and Lewandowska, Agnieszka and Szymusik, Iwona and Brawura-Biskupski-Samaha, Robert},
title = {Maternal SARS-CoV-2 Infection at Delivery Increases IL-6 Concentration in Umbilical Cord Blood},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {17},
pages = {5672},
doi = {10.3390/jcm12175672}
}
EUVIMED